In vitro model to estimate gut inflammation using co-cultured Caco-2 and RAW264.7 cells

Biochemical and Biophysical Research Communications

Volumn 374, Issue 3, 2008, Pages 565-569

  Tanoue, Takeshi ^a   Nishitani, Yosuke ^a   Kanazawa, Kazuki ^a   Hashimoto, Takashi ^a   Mizuno, Masashi ^a  

^a KOBE UNIVERSITY   (Japan)

Author keywords

Caco 2 cells; Co culture; Fucoidan; Gut inflammation; IL 8; TER; TNF

Indexed keywords

FUCOIDIN; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; POLYSACCHARIDE SULFATE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL LINE; CELL STRAIN CACO 2; CELL STRAIN RAW 264.7; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; INTESTINE; NONHUMAN; PRIORITY JOURNAL;

ALGAE, BROWN; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CACO-2 CELLS; COCULTURE TECHNIQUES; COLITIS; GENE EXPRESSION; HUMANS; INTERLEUKIN-8; MICE; MODELS, BIOLOGICAL; POLYSACCHARIDES; RNA, MESSENGER; SULFATES; TUMOR NECROSIS FACTOR-ALPHA;

PHAEOPHYCEAE;

EID: 48849106386     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.07.063     Document Type: Article

References (35)

1. Arai F., Takahashi T., Furukawa K., Matsushima K., and Asakura H. Mucosal expression of interleukin-6 and interleukin-8 messengerRNA in ulcerative colitis and Crohn's disease. Dig. Dis. Sci. 43 (1999) 2071-2079
2. Clayburgh D.R., Shen L., and Turner J.R. A porous defense: the leaky epithelial barrier in intestinal disease. Lab. Invest. 84 (2004) 282-291
3. Chin A.C., and Parkos C.A. Neutrophil transepithelial migration and epithelial barrier function in IBD: potential targets for inhibiting neutrophil trafficking. Ann. NY Acad. Sci. 1072 (2006) 276-287
4. Struyf S., Gouwy M., Dillen C., Proost P., Opdenakker G., and Damme J.V. Chemokines synergize in the recruitment of circulating neutrophils into inflamed tissue. Eur. J. Immunol. 35 (2005) 1583-1591
5. Zareie M., Singh P.K., Irvine E.J., Sherman P.M., McKay D.M., and Perdue M.H. Monocyte/macrophage activation by normal bacteria and bacterial products: implications for altered epithelial function in Crohn's disease. Am. J. Pathol. 158 (2001) 1101-1109
6. Murch S.H., Braegger C.P., Walker-Smith J.A., and MacDonald T.T. Location of tumour necrosis factor a by immunohistochemistry in chronic inflammatory bowel disease. Gut 34 (1993) 1705-1709
7. Gerard C., and Rollins B.J. Chemokines and disease. Nat. Immunol. 2 (2001) 108-115
8. Duarte M.E.R., Cardoso M.A., Noseda M.D., and Cerezo A.S. Structural studies on fucoidans from the brown seaweed Sargassum stenophyllum. Carbohydr. Res. 333 (2001) 281-293
9. Cumashi A., Ushakova N.A., Preobrazhenskaya M.E., D'Incecco A., Piccoli A., Totani L., Tinari N., Morozevich G.E., Berman A.E., Bilan M.I., Usov A.I., Ustyuzhanina N.E., Grachev A.A., Sanderson C.J., Kelly M., Rabinovich G.A., Iacobelli S., and Nifantiev N.E. A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds. Glycobiology 17 (2007) 541-552
10. Hsu H.Y., Chiu S.L., Wen M.H., Chen K.Y., and Hua K.F. Ligands of macrophage scavenger receptor induce cytokine expression via differential modulation of protein kinase signaling pathways. J. Biol. Chem. 276 (2001) 28719-28730
11. Choi E.M., Kim A.J., Kim Y.O., and Hwang J.K. Immunomodulating activity of arabinogalactan and fucoidan in vitro. J. Med. Food 8 (2005) 446-453
12. Kim M.H., and Joo H.G. Immunostimulatory effects of fucoidan on bone marrow-derived dendritic cells. Immunol. Lett. 115 (2008) 138-143
13. Matsumoto S., Nagaoka M., Hara T., Kimura-Takagi I., Mistuyama K., and Ueyama S. Fucoidan derived from Cladosiphon okamuranus Tokida ameliorates murine chronic colitis through the down-regulation of interleukin-6 production on colonic epithelial cells. Clin. Exp. Immunol. 136 (2004) 432-439
14. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., and Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis. Gut 98 (1990) 694-702
15. Morris G.P., Beck P.L., Herridge M.S., Depew W.T., Szewczuk M.R., and Wallace J.L. Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology 96 (1989) 795-803
16. Watanabe M., Ueno Y., Yajima T., Okamoto S., Hayashi T., Yamazaki M., Iwao Y., Ishii H., Habu S., Uehira M., Nishimoto H., Ishikawa H., Hata J., and Hibi T. Interleukin 7 transgenic mise develop chronic colitis with decreased interleukin 7 protein accumulation in the colonic mucosa. J. Exp. Med. 187 (1998) 389-402
17. Sadlack B., Merz H., Schorle H., Schimpl A., Feller AC., and Horak I. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75 (1993) 253-261
18. Kühn R., Löhler J., Rennick D., Rajewsky K., and Müller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75 (1993) 263-274
19. Clarke J.O., and Mullin G.E. A review of complementary and alternative approaches to immunomodulation. Nutr. Clin. Pract. 23 (2008) 49-62
20. Chan E.P., and Lichtenstein G.R. Chemoprevention: risk reduction with medical therapy of inflammatory bowel disease. Gastroenterol. Clin. North Am. 35 (2006) 675-712
21. Hidalgo I.J., Raub T.J., and Borchardt R.T. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology 96 (1989) 736-749
22. Takada K., Ohno N., and Yadomae T. Binding of lysozyme to lipopolysaccharide suppresses tumor necrosis factor production in vivo. Infect. Immun. 62 (1994) 1171-1175
23. Saegusa S., Totsuka M., Kaminogawa S., and Hosoi T. Candida albicansand and Saccharomyces cerevisiae induce interleukin-8 production from intestinal epithelial-like Caco-2 cells in the presence of butyric acid. FEMS Immunol. Med. Microbiol. 41 (2004) 227-235
24. Bouma G., and Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3 (2003) 521-533
25. Sartor R.B. Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126 (2004) 1620-1633
26. MacDermott R.P. Chemokines in the inflammatory bowel diseases. J. Clin. Immunol. 19 (1999) 266-272
27. Suenaert P., Bulteel V., Lemmens L., Noman M., Geypens B., Assche G.V., Geboes K., Ceuppens J.L., and Rutgeerts P. Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease. Am. J. Gastroenterol. 97 (2002) 2000-2004
28. Dongmei Y., Iris M., and Thomas Y.M. Molecular mechanism of tumor necrosis factor-α modulation of intestinal epithelial tight junction barrier. Am. J. Physiol. Gastrointest. Liver Physiol. 290 (2006) 496-504
29. Satsu H., Ishimoto Y., Nakano T., Mochizuki T., Iwanaga T., and Shimizu M. Induction by activated macrophage-like THP-1 cells of apoptotic and necrotic cell death in intestinal epithelial Caco-2 monolayers via tumor necrosis factor-alpha. Exp. Cell Res. 312 (2006) 3909-3919
30. Mizuno M., Kawakami S., Sakamoto Y., and Fujitake N. Macarophages stimulated by polysaccharide purified from Agaricus blansiliensis S. Wasser et al. (Agaricomcetideae) enhance mRNA expression of Th1 cytokine including IL-12 and 18. Int. J. Med. Mushroom 5 (2003) 383-389
31. Royle M.C., Tötemeyer S., Alldridge L.C., Maskell D.J., and Bryant C.E. Stimulation of Toll-like receptor 4 by lipopolysaccharide during cellular invasion by live Salmonella typhimurium is a critical but not exclusive event leading to macrophage responses. J. Immunol. 170 (2003) 5445-5454
32. Baggiolini M., Loetscher P., and Moser B. Interleuin-8 and the chemokine family. Int. J. Immunopharmacol. 17 (1995) 103-108
33. Ardizzone S., and Pooro G.B. Biologic therapy for inflammatory bowel disease. Drugs 65 (2005) 2253-2286
34. Clark A.R. Anti-inflammatory functions of glucocorticoid-induced genes. Mol. Cell. Endocrinol. 275 (2007) 79-97
35. Pahl A., Bauhofer A., Petzold U., Cnota P.J., Maus J., Brune K., and Szelenyi S. Synergistic effects of the anti-cholinergic R,R-glycopyrrolate with anti-inflammatory drugs. Biochem. Pharmacol. 72 (2006) 1690-1696